BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FXS0683 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of FXS0683\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07616089-3048@assetmemo.bio
DTSTAMP:20261121T005822Z
DTSTART;VALUE=DATE:20280807
DTEND;VALUE=DATE:20280808
SUMMARY:FXS0683: Phase 1 readout est. (NCT07616089)
DESCRIPTION:FXS0683\, phase 1\, Acute Myeloid Leukemia.\nStudy: Phase I Stu
 dy of FXS0683 in the Treatment of Blood Tumors\nEstimated primary completi
 on: 7 August 2028. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/fx
 s0683#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT07616089
URL:https://assetmemo.bio/drug/fxs0683#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
